Principal Financial Group’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-3,744
Closed -$365K 2268
2015
Q1
$365K Buy
3,744
+306
+9% +$29.8K ﹤0.01% 1879
2014
Q4
$319K Sell
3,438
-1,124
-25% -$104K ﹤0.01% 1918
2014
Q3
$314K Buy
4,562
+750
+20% +$51.6K ﹤0.01% 1912
2014
Q2
$399K Sell
3,812
-1,488
-28% -$156K ﹤0.01% 1898
2014
Q1
$440K Sell
5,300
-51
-1% -$4.23K ﹤0.01% 1891
2013
Q4
$346K Buy
5,351
+612
+13% +$39.6K ﹤0.01% 1954
2013
Q3
$300K Sell
4,739
-1,418
-23% -$89.8K ﹤0.01% 1962
2013
Q2
$259K Buy
+6,157
New +$259K ﹤0.01% 1989